Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Silverceuticals Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. The company's current prosecution activity is limited to this single active matter. The 1 pending office action represents the entire active portfolio for the applicant in the biotechnology sector.
HELM, CARALYNNE E is the busiest examiner, holding the 1 pending office action. With 1 distinct examiner and 1 distinct art unit, the applicant's focus is entirely on the feedback from this 1 source. This 1 to 1 ratio of pending actions to examiners means that practitioners can dedicate their efforts to the specific nuances of this examiner's approach within the Biotechnology & Pharmaceuticals sector. The use of 1 distinct art unit ensures that the prosecution strategy is tailored to the specific departmental standards of that group.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 36d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 36d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | 36d overdue | Pending | Jun 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSilverceuticals Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Caralynne E Helm has the most, with 1 of Silverceuticals Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
